Stock data
enVVeno Medical Corporation (NVNO)
enVVeno Medical Corporation (NVNO) reported net income of -US$19.47M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$20.90M | -US$19.47M | — |
| 2024 | — | — | -US$23.83M | -US$21.82M | — |
| 2023 | — | — | -US$25.24M | -US$23.52M | — |
| 2022 | — | — | -US$24.93M | -US$24.67M | — |
| 2021 | — | — | -US$16.89M | -US$16.53M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$3.60M | — |
| 2026-03-31 | — | -US$3.85M | — |
| 2025-12-31 | — | -US$3.74M | — |
| 2025-09-30 | — | -US$4.54M | — |
| 2025-06-30 | — | -US$6.69M | — |
| 2025-03-31 | — | -US$4.50M | — |
| 2024-12-31 | — | -US$6.23M | — |
| 2024-09-30 | — | -US$5.64M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.